Clinical trials
Phase 4 Musculoskeletal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 4 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carilion Clinic | 1 |
| Chinese University of Hong Kong | 1 |
| Emory University | 1 |
| Fondazione Policlinico Universitario Campus Bio-Medico | 1 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 1 |
| Hospital Infantil Albert Sabin | 1 |
| Miller Orthopedic Specialists | 1 |
| NHS Greater Glasgow and Clyde | 1 |
| Regionshospitalet Silkeborg | 1 |
| Seoul National University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Musculoskeletal Diseases | 14 |
| Joint Diseases | 2 |
| Low Back Pain | 2 |
| Agnosia | 1 |
| Arthritis | 1 |
| Athletic Injuries | 1 |
| Bone Diseases | 1 |
| Carpal Tunnel Syndrome | 1 |
| Connective Tissue Diseases | 1 |
| Contracture | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.